Back

What is the evidence for empagliflozin in HF?

22 May 2022 (15:00 - 15:10)
Organised by:
Congress Presentation Part of: A new era for HFpEF – Exploring the role of empagliflozin in practice Chronic Heart Failure Open Access Heart Failure 2022

About the speaker

Photo
Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
Using empagliflozin for HFpEF treatment - what does this look like in practice?
Doctor S. Zieroth (Winnipeg, CA)
Slides Video
Presentation thumbnail
Panel discussion and close.
Professor A. Stewart Coats (Sydney, AU)
Slides Video

Access the full session

Session thumbnail
A new era for HFpEF – Exploring the role of empagliflozin in practice
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 15:00 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources